Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
BridgeBio Pharma, Inc. (BBIO)
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/26/2021 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 14.4M | $0.00 | $0 | | 01/26/2021 |
| 07/03/2019 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 882.4k | $29.90 | $26.4M | See Footnote | 07/03/2019 |
| 05/24/2019 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 1.1M | $25.93 | $28.6M | | 05/24/2019 |
| 12/10/2018 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 38k | $13.29 | $504.9k | | 12/10/2018 |
| 12/10/2018 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 2.7k | $13.96 | $37.2k | | 12/10/2018 |
| 12/10/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 2.7k | $13.96 | $37.2k | | 12/10/2018 |
| 12/10/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 38k | $13.29 | $504.9k | | 12/10/2018 |
| 12/07/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 4.9k | $14.36 | $69.8k | | 12/06/2018 |
| 12/07/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 36.3k | $13.94 | $506.2k | | 12/06/2018 |
| 12/07/2018 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 4.9k | $14.36 | $69.8k | | 12/06/2018 |
| 12/07/2018 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 36.3k | $13.94 | $506.2k | | 12/06/2018 |
| 12/06/2018 | Eidos Therapeutics, Inc. | EIDX | Sale | Common Stock | 39k | $13.34 | $519.9k | | 12/06/2018 |
| 12/06/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 39k | $13.34 | $519.9k | | 12/06/2018 |
| 12/05/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 1.1M | $14.01 | $15.5M | | 12/03/2018 |
| 12/03/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 1.8M | $15.50 | $27.1M | | 12/03/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Exercise (in-the-money or at-the-money) | Series B Preferred Stock | 332.3k | $0.00 | $0 | | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Conversion | Series Seed Preferred Stock | 12.8M | $0.00 | $0 | | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Conversion | Series B Preferred Stock | 2.9M | $0.00 | $0 | | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Exercise (in-the-money or at-the-money) | Warrants | 332.3k | $10.83 | $3.6M | | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Purchase | Common Stock | 1000k | $17.00 | $17M | | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Payment of Exercise | Common Stock | 211.8k | $17.00 | $3.6M | | 06/22/2018 |
| 06/22/2018 | Eidos Therapeutics, Inc. | EIDX | Conversion | Common Stock | 18.8M | $0.00 | $0 | | 06/22/2018 |
|